Rodrigo Quera

9PUBLICATIONS
55CO-AUTHORS
Nanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 25, 2026
Comment on: "Safety of thiopurines in inflammatory bowel diseases: neither so good, nor so bad".

Francisca Carvajal, Rodrigo Quera, Gonzalo Pizarro

|Nov 17, 2025
Comment on: Dual advanced therapy in inflammatory bowel disease. Why, when and how?

Rodrigo Quera, Paulina Núñez, Gonzalo Pizarro

|Sep 29, 2025
Monitoring inflammatory activity in inflammatory bowel disease: not too far, not too close.

Rodrigo Quera, Paulina Núñez, Francisca Carvajal

|Apr 08, 2025
It's time to measure what matters in inflammatory bowel disease.

Joaquín González Aroca, Rodrigo Quera

|Jan 11, 2024
Mesalamine induced hepatotoxicity. Is mesalamine safe?

Javier Pérez-Valenzuela, Lorena Castro Solari, Rodrigo Quera

|Nov 06, 2023
Effectiveness of infliximab in common variable immunodeficiency associated with enteropathy.

Rodrigo Quera, Paulina Núñez Figueroa, Pía Zañartu

Pageof 2